Dilazep and dipyridamole inhibit tissue factor expression on monocytes induced by IgG from patients with antiphospholipid syndrome.
Zhou
Hong
H
Department of Clinical Laboratory and Hematology, Jiangsu University School of Medical Technology, Zhenjiang 212001, China. hongzhou0123@163.com
D018674:Adrenergic Antagonists / Q000494:pharmacology; D016736:Antiphospholipid Syndrome / Q000097:blood* / Q000276:immunology; D002469:Cell Separation; D004109:Dilazep / Q000494:pharmacology*; D004176:Dipyridamole / Q000494:pharmacology*; D015870:Gene Expression / Q000187:drug effects; D006801:Humans; D007074:Immunoglobulin G / Q000276:immunology / Q000494:pharmacology; D009000:Monocytes / Q000378:metabolism*; D010975:Platelet Aggregation Inhibitors / Q000494:pharmacology; D012333:RNA, Messenger / Q000096:biosynthesis / Q000235:genetics; D013806:Theophylline / Q000494:pharmacology; D013925:Thromboplastin / Q000096:biosynthesis* / Q000235:genetics
D018674:Adrenergic Antagonists; D007074:Immunoglobulin G; D010975:Platelet Aggregation Inhibitors; D012333:RNA, Messenger; D004176:Dipyridamole; D013925:Thromboplastin; D013806:Theophylline; D004109:Dilazep